Innate Pharma (IPHA) Interest Coverage Ratio Growth (3y) (2022 - 2025)
Innate Pharma (IPHA) Interest Coverage Ratio Growth (3y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,681.27 Bn | 66,680.98 Bn | - | -42.41% |
| 2 | Nanobiotix | 1,946.26 Bn | 1,946.20 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 473.25 Bn | 468.46 Bn | 1.35 Bn | 28.11% |
| 5 | Vertex Pharmaceuticals | 123.17 Bn | 115.92 Bn | 2.59 Bn | -6.89% |
| 6 | Regeneron Pharmaceuticals | 69.54 Bn | 60.79 Bn | 3.31 Bn | 79.27% |
| 7 | Belite Bio | 63.20 Bn | 63.20 Bn | - | - |
| 8 | Argenx Se | 56.91 Bn | 51.72 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 38.23 Bn | 38.23 Bn | - | 29.47% |
| 10 | Innate Pharma | 157.68 Mn | 157.68 Mn | - | -82.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -82.43% |
| Dec 31, 2024 | 3.96% |
| Dec 31, 2023 | 65.90% |
| Dec 31, 2022 | 742.05% |